WO2014129763A1 - Method for manufacturing capsule and capsule for absorbent which is obtained therefrom - Google Patents

Method for manufacturing capsule and capsule for absorbent which is obtained therefrom Download PDF

Info

Publication number
WO2014129763A1
WO2014129763A1 PCT/KR2014/001070 KR2014001070W WO2014129763A1 WO 2014129763 A1 WO2014129763 A1 WO 2014129763A1 KR 2014001070 W KR2014001070 W KR 2014001070W WO 2014129763 A1 WO2014129763 A1 WO 2014129763A1
Authority
WO
WIPO (PCT)
Prior art keywords
capsule
acid
present
solution
sodium
Prior art date
Application number
PCT/KR2014/001070
Other languages
French (fr)
Korean (ko)
Inventor
윤영상
원성욱
프라탑코테
Original Assignee
전북대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 전북대학교산학협력단 filed Critical 전북대학교산학협력단
Publication of WO2014129763A1 publication Critical patent/WO2014129763A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/20After-treatment of capsule walls, e.g. hardening
    • B01J13/206Hardening; drying
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/26Synthetic macromolecular compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/04Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B01J13/046Making microcapsules or microballoons by physical processes, e.g. drying, spraying combined with gelification or coagulation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02Making microcapsules or microballoons
    • B01J13/20After-treatment of capsule walls, e.g. hardening
    • B01J13/22Coating

Definitions

  • the present invention relates to a capsule manufacturing method and a capsule for adsorption by the same, and more particularly, a capsule manufacturing method for improving valuable metal recovery performance and selectivity to the tackifier metal by containing a functional material on the surface or inside thereof, and a capsule for the adsorbent thereby. It is about.
  • waste electronic products are discharged as waste along with industrial wastewater generated during the manufacturing process of electronic products.
  • Industrial wastewater and electronic waste products are the main contributors to the environment, but they also contain valuable metals such as gold, silver, and copper, and they have high recycling value.
  • the average valuable metal contained in one waste cell phone is worth 0.024g of gold, 0.14g of silver, and 10.5g of copper, which is worth more than 1,500 won. Resource conservation effect of about 750 million won will occur.
  • Korean Unexamined Patent Publication No. 10-2012-87678 discloses a method of removing a heterometal oxide adsorbent for removing bromate using a hydrogel.
  • the method is characterized in that the bimetal oxide adsorbent containing two metals has higher surface charge than the one iron oxide adsorbent, so that the adsorption performance is improved, and the hydrogel cannot contain a reducing agent or the like. It is difficult to selectively recover bays.
  • 1 shows a mechanism for producing beads by a conventional method. Referring to FIG. 1, conventionally, a capsule was prepared by dropping a polymer bead into an uncoagulant (eg, chloride). In the method for preparing beads according to FIG.
  • an uncoagulant eg, chloride
  • the polymers in the solution are cured from the outside to the inside to prepare the beads.
  • the method is limited in the content of the functional material, and it is difficult to contain the hydrophobic functional material. There are a number of problems, such as the release of functional materials.
  • the present invention is to provide a capsule for the adsorbent with improved recovery capacity of valuable metals.
  • the present invention provides an adsorbent capsule capable of selectively recovering a specific metal and a method for manufacturing the same.
  • the present invention provides a new capsule manufacturing method that can easily contain the desired functional material in the capsule, unlike the conventional bead manufacturing method.
  • the present invention is to provide a new capsule and a method for manufacturing the same that can maintain the shape while receiving a functional material therein for a long time.
  • One aspect of the present invention comprises the steps of mixing a functional material and a quaternary agent
  • a step of dropping the mixed solution into a polymer solution wherein the step of curing the polymer from the outside of the drop-shaped mixing solution in which the polymer is dropped to form a film having a predetermined thickness, and containing a functional material in the film It relates to a capsule manufacturing method comprising a.
  • the present invention relates to a cap for adsorbent prepared by the above method.
  • the capsule for adsorption of the present invention may contain a desired functional material in the capsule, and it is possible to maintain the shape while receiving them for a long time.
  • a polymer capsule granulated with a functional material such as a metal extracting agent, it is possible to improve the metal recovery performance and to selectively recover only a specific metal.
  • the method according to the present invention can simplify the process compared to the conventional wet smelting method because the solid-liquid separation is possible in the recovery of valuable metals, and secondary sludge does not occur. This makes the process more environmentally friendly.
  • FIG. 1 is a schematic view showing a conventional bead manufacturing method.
  • FIG. 2 shows a schematic view of a capsule for an adsorbent according to the present invention.
  • FIG. 3 is a schematic diagram of an apparatus for making a capsule of the present invention.
  • FIG. 4 illustrates a process of forming a capsule in the capsule former 130.
  • FIG. 5 is a schematic diagram showing that when the capsule prepared in FIG. 4 is injected into a separate unpacking agent solution, the unpacking agent diffuses from the outside to the inside.
  • Example 6 is an electron micrograph of the capsule or the beads obtained in Example 1, Example 4 and Comparative Example 1.
  • FIG. 7 is a graph showing that the adsorption test was performed using the capsule of Example 1.
  • FIG. 8 is a graph showing that the adsorption test was performed using the capsule of Example 2.
  • FIG. 9 is a graph showing that the adsorption test was performed using the camshade of Example 3.
  • One embodiment of the present invention relates to a method for preparing a capsule by injecting a mixed solution of a functional substance and a male agent in a polymer solution.
  • a functional substance and an ointment are mixed, and then dropped into a polymer solution to prepare 3 ⁇ 4 slots.
  • the mixed solution is preferably added dropwise to the polymer solution in the form of beads.
  • the polymer surrounds the dropped mixed solution to form a wall having a predetermined thickness, and the uncoagulant pressurizes the inside of the formed polymer wall to the outside to maintain the shape of the polymer wall.
  • Capsules prepared by the present invention contain a functional material therein or on the surface, where the expression “containing” means that the functional material is contained or contained within the capsule, and is precipitated or adsorbed on the capsule surface. It may indicate that it is coated. Furthermore, the expression “contains” means that the functional material, together with the polymer, forms the outer layer (shell) of the capsule. It does not exclude forming or supporting in the outer layer.
  • the capsul 100 of the present invention includes an interior region 10 and a wall 20.
  • the inner region 10 contains the functional material and the ointment.
  • the wall 20 forms a wall surrounding the mixed solution as the polymer solidifies.
  • the thickness of the wall 20 may be 1-5,000, preferably 10-1,000.
  • the manufacturing apparatus of the present invention includes a mixer 110, an injector 120, and a capsule former 130.
  • a mixed solution is prepared by mixing a functional solution and an ointment agent.
  • the mixer may further mix high viscosity materials.
  • the injector 120 drops the mixed solution provided from the mixer 110 to the capsule former 130.
  • the injection unit 120 may be provided with a nozzle that can drop the mixed solution at predetermined intervals.
  • the manufacturing apparatus of the present invention may include a transfer unit 140 for providing the mixed solution to the injection unit.
  • the capsule former 130 is filled with a polymer solution.
  • the mixed solution is dropped into the polymer solution in the form of beads, the polymer in contact with the interface of the beads is cured to form a wall of a predetermined thickness.
  • the capsule former 130 may be provided with a stirrer.
  • FIG. 4 illustrates a capsule formation process in the capsule former 130.
  • CaC12 is used as an unpacking agent.
  • Ca 2+ ionized inside the beads diffuses into the polymer solution surrounding the beads, thereby curing the polymer in the solution from the bead surface.
  • the method and manufacturing apparatus of the present invention can arbitrarily adjust the curing rate or thickness of the polymer wall by controlling the concentration of uncoagulant, such as Ca 2+ , and the polymer concentration in the capsule maker 130 inside the bead.
  • uncoagulant such as Ca 2+
  • the capsule manufacturing method of the present invention may contain a large amount of functional material compared to the conventional bead or hydrogel manufacturing method, and the conventional technology has a great difficulty in containing a hydrophobic functional material, but the present technology provides a hydrophobic functional material easily. It may contain.
  • the present invention is a polymer material modification and containing according to the functional material containing There is no leakage of functional material and the capsule thickness can be easily adjusted, so high adsorption rate can be expected in terms of mass transfer.
  • the capsule manufacturing method and apparatus of the present invention may further include a step and a device for injecting the capsule formed by the dropping step into a separate coagulant solution.
  • Figure 5 shows the action of the uncoagulant appearing after injecting the capsule prepared in Figure 4 into the coagulant solution.
  • the coagulant is present only in the inside, but in the case of FIG. 5, the coagulant is also present in the polymer outer wall, and the uncoagulant diffuses from the outer wall to the inside to form the polymer outer wall more firmly.
  • the functional material may be any one or more of a metal reducing agent, a metal extractant, and a chelating compound.
  • the metal reducing agent is a natural antioxidant, tocopherols, flavone derivatives, phyl lozurcins, gal lie acid derivatives, catechin, nordihydroguaiaret ic acid, gossypol, lignan glycosides, plant extracts and polymers having metal reducing power, glutaraldehyde ( Glutaraldehyde), Sodium borohydride (NaBH 4 ), Hydrazine ( ⁇ 2 ⁇ 4 ),
  • Hydroquinone ((3 ⁇ 40 2), Sodium oxalate (Na 2 C2H 2 0 4), Formic acid, may be at least one selected from Dimethylamine borane, Dithiothreitol, and Tris (2-carboxyethyl) phosphine.
  • the metal extractant may be an organophosphorus derivative (eg, tri isobutyl phosphine sulfide, trioctylphosphine oxide, tri alky lphosphine oxide), trioctylamine, methyl isobutyl ketone, trioctylmethyl Trioctylmethylammonium chloride, dibutyl sulfoxide, tris-iso-octyl amine, LIX 841 (tri pheny 1 hosph i ne, 2 ⁇ hydroxyl— 5 ⁇ nonylacetophenoneoxime), phospho 1 ic acid di (2- ethylhexyl) ester, tri—butyl phosphate, elex-100 (7- (4-ethyl-l-methyloctyl) -8-hydroxyquinol ine), alkyl sulfides, phosphine sulfide, hydroxyoxime derivatives (hydroxyoximes), secondary amines,
  • the chelating agent examples include polyphosphate (for example, sodium triplyphosphate, nucleus metaphosphate, sodium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, sodium metaphosphate and sodium metaphosphate. ); Aminocarboxylic acids (e.g., ethylenediaminetetraacetic acid (EDTA), 1,2-bis (2-amino ⁇ phenoxy) ethane-N, ⁇ , ⁇ ' ⁇ '-tetraacetic acid (EGTA), ethylenebis (Oxyethylenenitrilo) tetraacetic acid ( ⁇ ), ⁇ - (hydroxyethyl) -ethylenediaminetriacetic acid (HEDTA), diethylenetriaminepentaacetic acid (DTPA), ⁇ -dihydroxyethylglycine (2- HxG), ethylenebis (hydroxyphenyl-glycine) (EHPG), glutamic acid, aspartic acid, glycine, lysine); 1,3—dike
  • nitrilotrimethylenephosphonic acid ethylenediaminetetra- (methylenephosphonic acid), hydroxy to Thylidenediphosphonic acid), melamine L-cystein, Phosphatidylcholone, and alamin.
  • chelating agent melamine, L-cystein,
  • Phosphatidylcholone or alamin can be used.
  • the uncoagulant may be sodium polyphosphate, calcium chloride, ethane, water or caustic soda solution.
  • the polymer is chitosan, alginate, dextran, oxidized dextran, heparan, heparin, hyaluronic acid, agarose. ), Carageenan, amylopectin amylopectin, amylose, glycogen, starch, salose, chitin, heparan sulfate, chondroitin sulfate, dextran sulfate, dermatan sulfate dermatan sulfate, keratan sulfate, pectins, xanthanGum, carboxymethyl cellulose, homopolymers and copolymers of acrylamide, polyacrylic acid, polyethylene oxide, polyvinyl alcohol, polyvinyl It may be at least one selected from the group consisting of alcohol-polyvinylacetate copolymer, poly (N-vinylpyridone), polyhydroxyethyl acrylate, polysulfone, and polyurethane
  • the polymer may be dissolved in an appropriate solvent and used as the solvent.
  • the polymer is cured from the outside of the bead-shaped mixed solution to the inside to form a film having a predetermined thickness.
  • the concentration of the polymer solution is 0.01 to 80% (w / v), 0.01 to 50% (w / v) of the functional material and 0.01 ⁇ 403 ⁇ 4> (w / v) of the coagulant in comparison to the polymer solution Can be used.
  • the method further includes a high viscosity material in the mixed solution, and the functional material may be granulated by the high viscosity material.
  • a capsule may be formed in the form of coating the complex beads from the outside.
  • a predetermined viscosity is obtained by mixing a functional material and a high viscosity material.
  • the functional substance can be stably contained in the capsule because it is in the state of the excitation emulsion.
  • the highly viscous material may be added in an amount of 0.01 to 50 parts by weight, preferably 1 to 20 parts by weight, based on 100 parts by weight of the functional material so that the functional material does not elute to the outside of the capsule. If it is less than 0.01 part by weight, it is difficult to block the granulation of the functional material and to elute out of the capsule, and when it exceeds 50 parts by weight, it is difficult to drop the solution with excessive viscosity.
  • the high viscosity material may be used having a viscosity of 2 ⁇ 10,000 mPa s.
  • the highly viscous materials include Carboxymethyl Cellulose, Hydroxyethyl Cellulose, Xanthan Gum, Hycel, Carbomer, Gelatin ), Pectin, Guargum, Sodium Alginate, Calcium Glycerophosphate, Carrageenan, Tragacanth gum, Propylene Glycol Glycol Alginate, Methylethylcel lulose, Potassium Alginate and Carboxymethylcelluloseose calcium (Calcium Carboxymethylcel lulose)
  • Capsule for the adsorbent of the present invention is a functional material melamine, L-cystein, Phosphatidylcholone, dibutyl sulfoxide, LIX
  • the capsule may have a selective adsorption capacity for gold, including aamine (alamine), methyl isobutyl ketone as a functional material.
  • the capsule for the adsorbent may be visually determined by the replacement cycle of the capsule using an oil component among the aforementioned functional materials.
  • an oily component may be alumina, melamine and the like.
  • the capsule is settled to the bottom at the top of the solution by increasing the specific gravity as the valuable metal adsorbs.
  • the adsorbed metal floats to the top of the desorption process.
  • the valuable metal recovery method according to the present invention a specific valuable metal can be selectively recovered.
  • the method according to the present invention can be separated by solid-liquid separation in valuable metal recovery, it is possible to operate an environmentally friendly process.
  • the capsule obtained above was added to 100 mL of 2% CaC12 solution and stirred for about 30 minutes. After reaction was completed, the 3 ⁇ 4 capsule was washed several times with deionized water.
  • a capsule was prepared in the same manner as in Example 1 except for adding 4 g of L-Cistein instead of melamine.
  • Capsules were prepared in the same manner as in Example 1 except for adding 4 g of Phosphatidylcholone instead of melamine.
  • the capsule of the present invention can be seen that the outer wall is formed to a predetermined thickness, but the wall of the predetermined thickness is not formed in the beads of Comparative Example 1.
  • FIG. 6 shows that the functional material is mixed with the high viscosity material and granulated in an emulsion state.
  • FIG. 7 is a graph showing that the adsorption test was carried out using the capsule of Example 1
  • Figure 8 is a graph showing that the adsorption test was performed using the capsule of Example 2
  • Figure 9 is carried out It is a graph showing that the adsorption test was performed using the capsule of Example 3.
  • the present invention relates to a method for preparing a capsule having a functional material contained on or inside a surface thereof, and to improving the valuable metal recovery performance and selectivity with respect to a specific metal, and to a capsule for the adsorbent, which can be used in the valuable metal recovery industry.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Abstract

The present invention relates to a method for manufacturing a capsule with which the selectivity in relation to specific metals and valuable metal recovery performance are improved by including functional substances on the surface or in the inside; and a capsule for an absorbent which is obtained by the method. The capsule for an absorbent of the present invention is capable of including required functional substances in the inside the capsule unlike with conventional beads, and the capsule is capable of maintaining its form while storing the substances for a long period of time. According to the present invention, by providing a high-molecular capsule in which functional substances such as a metal extraction agent are granulated, the metal recovery performance is improved and specific metals are selectively recovered. The method according to the present invention allows a solid/liquid separation for a valuable metal recovery, and thus the process can be simpler than a conventional hydrometallurgy mode, and since there is no second production of sludge, the process can be carried out in the more environmentally friendly manner.

Description

【명세서】  【Specification】
【발명의 명칭】  [Name of invention]
캡슐 제조방법 및 이에 의한 흡착제용 캡슐  Capsule manufacturing method and capsule for adsorbent thereby
【기술분야】  Technical Field
본 발명은 캡슐 제조방법 및 이에 의한 흡착제용 캡슐에 관한 것으로, 더욱 상세하게는 기능성 물질을 표면이나 내부에 함유하여 유가금속 회수 성능 및 톡정 금속에 대한 선택성이 향상된 캡슐 제조방법 및 이에 의한 흡착제용 캡슐에 관한 것이다.  The present invention relates to a capsule manufacturing method and a capsule for adsorption by the same, and more particularly, a capsule manufacturing method for improving valuable metal recovery performance and selectivity to the tackifier metal by containing a functional material on the surface or inside thereof, and a capsule for the adsorbent thereby. It is about.
【배경기술】  Background Art
전자제품의 수요가 급증함에 따라 전자제품 제조 공정시 발생하는 산업폐수 와 함께 각종 폐전자제품이 쓰레기로 배출되는 실정이다. 산업폐수나 폐전자제품은 환경을 오염시키는 주범이기도 하지만 금, 은, 동 등의 유가금속이 함유되어 있어 재활용가치가 높기도 하다. 예를 들면 폐휴대전화 1대에 들어 있는 평균 유가금속 은 금 0.024g, 은 0.14g, 구리 10.5g 등으로 약 1,500원 이상의 가치가 있으며, 50 만대의 폐휴대전화를 수거해 재활용을 하면 약 7억 5천만원의 자원보전효과가 발생 한다.  As demand for electronic products increases rapidly, various waste electronic products are discharged as waste along with industrial wastewater generated during the manufacturing process of electronic products. Industrial wastewater and electronic waste products are the main contributors to the environment, but they also contain valuable metals such as gold, silver, and copper, and they have high recycling value. For example, the average valuable metal contained in one waste cell phone is worth 0.024g of gold, 0.14g of silver, and 10.5g of copper, which is worth more than 1,500 won. Resource conservation effect of about 750 million won will occur.
최근 자원고갈 위기에 대처하기 위하여 자원의 재활용문제가 세계적 이슈이 다. 새로운 자원을 발견한다는 것은 점점 한계에 도달하고 있어 자원고갈 위기에 대웅하기 위하여 대체 재료나 폐자원 활용 등의 근본적인 해결방안을 강구하여야 할 필요성이 크다.  In order to cope with the recent resource exhaustion crisis, the recycling of resources is a global issue. The discovery of new resources is reaching its limit, and there is a great need to find fundamental solutions such as the use of alternative materials and waste resources to address the crisis of resource depletion.
산업폐수나 폐전자제품올 통한 자원보전효과를 얻기 위해서는 무엇보다 중요 한 것이 유가금속을 회수하는 방법이다. 폐수로부터 유가금속의 회수를 위해 현재 일반적으로 사용되는 방법은 금속추출제를 이용하는 방법이다. 그러나 금속추출제 를 이용하는 경우는 연속적으로 대규모의 공정이 요구되고 2차 오염물을 발생시키 는 문제점을 가지고 있다. 이를 해결하기위한 친환경적인 소재를 이용하여 유가금 속을 회수하기 위한 연구가 활발하게 이루어지고 있으며, 대표적인 방법으로는 알 지네이트, 키토산, 샐를로오즈 등의 하이드로겔을 이용하는 것이다.  The most important way to recover resources through industrial wastewater and waste electronic products is to recover valuable metals. The currently commonly used method for the recovery of valuable metals from waste water is the use of metal extractants. However, the use of a metal extractant has a problem of requiring a large-scale continuous process and generating secondary pollutants. In order to solve this problem, researches to recover the poultry in the poultry are being actively conducted, and a representative method is to use hydrogels such as alginate, chitosan and salloose.
예를 들면, 한국 공개 특허 10-2012-87678호에는 하이드로겔을 이용한 브름 산염 제거용 이종금속산화물 흡착제의 제거방법이 개시되어 있다. 상기 방법은 2 가지 금속이 포함된 이금속산화물 흡착제는 1종의 철산화물 흡착제에 비해 표면 전 하도가 높아 흡착성능이 향상되는 특징이 있으나, 하이드로겔 내부에 환원제 등을 함유할 수 없고, 특정 금속만을 선택적으로 회수하기 어렵다. <6> 도 1은 종래 방법으로 비드를 제조하는 메카니즘을 보여준다. 도 1을 참고하 면, 종래에는 고분자 비드를 웅고제 (염화칼슴 등)에 떨어뜨려 캡슐을 제조하였다. 도 1에 의한 비드 제조방법에서는 웅고제가 비드 내부로 확산하면서 용액 중 고분 자가 외부에서 내부로 경화되어 비드가 제조되는데, 그러나, 상기 방법은 기능성 물질의 함유량에 제한이 따르며, 소수성 기능성 물질 함유가 어려우며, 기능성 물 질이 유출될 수 있는 등 여러 문제들이 있다. For example, Korean Unexamined Patent Publication No. 10-2012-87678 discloses a method of removing a heterometal oxide adsorbent for removing bromate using a hydrogel. The method is characterized in that the bimetal oxide adsorbent containing two metals has higher surface charge than the one iron oxide adsorbent, so that the adsorption performance is improved, and the hydrogel cannot contain a reducing agent or the like. It is difficult to selectively recover bays. 1 shows a mechanism for producing beads by a conventional method. Referring to FIG. 1, conventionally, a capsule was prepared by dropping a polymer bead into an uncoagulant (eg, chloride). In the method for preparing beads according to FIG. 1, as the uncoagulant diffuses into the beads, the polymers in the solution are cured from the outside to the inside to prepare the beads. However, the method is limited in the content of the functional material, and it is difficult to contain the hydrophobic functional material. There are a number of problems, such as the release of functional materials.
【발명의 상세한 설명】  [Detailed Description of the Invention]
【기술적 과제】  [Technical problem]
<7> 본 발명은 유가금속의 회수능력을 향상시킨 흡착제용 캡슐을 제공하는 것이 다..  <7> The present invention is to provide a capsule for the adsorbent with improved recovery capacity of valuable metals.
<8> 본 발명은 특정 금속을 선택적으로 회수할 수 있는 흡착제 캡슐 및 이의 제 조방법을 제공하는 것이다.  The present invention provides an adsorbent capsule capable of selectively recovering a specific metal and a method for manufacturing the same.
<9> 본 발명은 종래 비드 제조방법과 달리 캡슐 내부에 원하는 기능성 물질을 용 이하게 내포할 수 있는 새로운 캡슐 제조방법을 제공하는 것이다.  The present invention provides a new capsule manufacturing method that can easily contain the desired functional material in the capsule, unlike the conventional bead manufacturing method.
<10> 본 발명은 내부의 기능성 물질을 장기간 수용하면서도 형상 유지가 가능한 새로운 캡슐 및 이의 제조방법을 제공하는 것이다. The present invention is to provide a new capsule and a method for manufacturing the same that can maintain the shape while receiving a functional material therein for a long time.
【기술적 해결방법】  Technical Solution
<u> 본 발명의 하나의 양상은 기능성 물질과 웅고제를 혼합하는 단계 ;  <u> One aspect of the present invention comprises the steps of mixing a functional material and a quaternary agent;
<12> 상기 흔합용액을 고분자 용액에 적하하는 단계로서, 상기 단계는 상기 고분 자가 적하된 방울 형태 흔합용액 외부에서부터 내부로 경화되어 소정 두께의 막을 형성하고, 상기 막 내부에 기능성 물질이 함유되는 단계를 포함하는 캡슐 제조방법 에 관계한다 .  <12> A step of dropping the mixed solution into a polymer solution, wherein the step of curing the polymer from the outside of the drop-shaped mixing solution in which the polymer is dropped to form a film having a predetermined thickness, and containing a functional material in the film It relates to a capsule manufacturing method comprising a.
<13> 또 다른 양상에서 본 발명은 상기 방법으로 제조된 흡착제용 캡슬에 관계한 다.  In another aspect, the present invention relates to a cap for adsorbent prepared by the above method.
【유리한 효과】  Advantageous Effects
<14> 본 발명의 흡착용 캡슐은 종래 비드와 달리 캡술 내부에 원하는 기능성 물질 을 함유할 수 있고, 이들을 장기간 수용하면서도 형상 유지가 가능하다.  Unlike the conventional beads, the capsule for adsorption of the present invention may contain a desired functional material in the capsule, and it is possible to maintain the shape while receiving them for a long time.
<15> 본 발명에 따르면, 금속 추출제 등 기능성 물질을 입상화시킨 고분자캡슐을 제공함으로써 금속 회수 성능을 향상시킬 수 있고 특정 금속만 선택적으로 회수할 수 있다.  According to the present invention, by providing a polymer capsule granulated with a functional material such as a metal extracting agent, it is possible to improve the metal recovery performance and to selectively recover only a specific metal.
<16> 본 발명에 의한 방법은 유가금속회수에 있어서 고액분리가 가능하므로 기존 의 습식제련방식에 비하여 공정을 단순화 시킬 수 있으며, 2차 슬러지가 발생하지 않기 때문에 보다 공정을 친환경적으로 운용할 수 있다. The method according to the present invention can simplify the process compared to the conventional wet smelting method because the solid-liquid separation is possible in the recovery of valuable metals, and secondary sludge does not occur. This makes the process more environmentally friendly.
【도면의 간단한 설명】  [Brief Description of Drawings]
<17> 도 1은 종래 비드 제조방법을 나타내는 개략도이다. 1 is a schematic view showing a conventional bead manufacturing method.
<18> 도 2는 본 발명에 의한 흡착제용 캡슐의 개략도를 나타낸다.  2 shows a schematic view of a capsule for an adsorbent according to the present invention.
<19> 도 3은 본 발명의 캡슐을 제조하는 장치의 개략도이다.  3 is a schematic diagram of an apparatus for making a capsule of the present invention.
<20> 도 4는 상기 캡슐 형성기 (130)에서의 캡술 형성 과정을 나타낸다.  4 illustrates a process of forming a capsule in the capsule former 130.
<2i> 도 5는 도 4에서 제조된 캡슬을 별도의 웅고제 용액에 주입하는 경우, 웅고 제가 캡슐 외부에서 내부로 확산되는 것을 보여주는 모식도이다.  <2i> FIG. 5 is a schematic diagram showing that when the capsule prepared in FIG. 4 is injected into a separate unpacking agent solution, the unpacking agent diffuses from the outside to the inside.
<22> 도 6은 실시예 1, 실시예 4 및 비교예 1에서 수득한 캡슐 또는 비드의 전자 현미경 사진이다. 6 is an electron micrograph of the capsule or the beads obtained in Example 1, Example 4 and Comparative Example 1.
<23> 도 7은 실시예 1의 캡슐을 사용하여 상기 흡착시험을 수행한 것을 보여주는 그래프이다.  FIG. 7 is a graph showing that the adsorption test was performed using the capsule of Example 1. FIG.
<24> 도 8은 실시예 2의 캡슐을 사용하여 상기 흡착시험을 수행한 것을 보여주는 그래프이다.  8 is a graph showing that the adsorption test was performed using the capsule of Example 2. FIG.
<25> 도 9는 실시예 3의 캠슬을 사용하여 상기 흡착시험을 수행한 것을 보여주는 그래프이다.  9 is a graph showing that the adsorption test was performed using the camshade of Example 3. FIG.
<26>  <26>
【발명의 실시를 위한 형태】  [Form for implementation of invention]
<27> 이하에서 본 발명을 더욱 상세하게 설명한다 .  Hereinafter, the present invention will be described in more detail.
<28> 본 발명의 일구현예는 기능성 물질과 웅고제의 흔합용액을 고분자 용액에 주 입하여 캡슐을 제조하는 방법에 관계한다.  One embodiment of the present invention relates to a method for preparing a capsule by injecting a mixed solution of a functional substance and a male agent in a polymer solution.
<29> 본 발명에서는 먼저 기능성 물질과 웅고제를 흔합한 후 이를 고분자 용액에 적하하여 ¾슬을 제조한다 . In the present invention, first, a functional substance and an ointment are mixed, and then dropped into a polymer solution to prepare ¾ slots.
<30> 상기 흔합용액을 고분자 용액에 비드 (bead)형태로 적하하여 주입하는 것이 바람직하다. 상기 적하단계는 상기 고분자가 상기 적하된 흔합용액을 둘러싸 소정 두께의 벽을 형성하고 상기 웅고제는 형성된 고분자 벽 내부에서 외부로 압력을 가해 고분자 벽의 형상을 공고히 유지한다.  The mixed solution is preferably added dropwise to the polymer solution in the form of beads. In the dropping step, the polymer surrounds the dropped mixed solution to form a wall having a predetermined thickness, and the uncoagulant pressurizes the inside of the formed polymer wall to the outside to maintain the shape of the polymer wall.
<31> 상기 적하단계를 통해 상기 기능성 물질은 형성된 고분자 벽 내부에 함유된 다. 본 발명에 의해 제조된 캡슐은 그 내부 또는 표면에 기능성 물질을 함유하는 데, 여기서 "함유 "라는 표현은 캡슐 내부에 기능성 물질이 담지 또는 내포된 것을 의미하고, 또한 캡슐 표면 상에 침전 내지 흡착되어 코팅된 것을 나타낼 수 있다. 더 나아가, "함유''라는 표현은 기능성 물질이 고분자와 함께 캡슐의 외층 (껍질)을 형성하거나 외층 내에 담지되는 것도 배제하지 않는다. Through the dropping step, the functional material is contained within the formed polymer wall. Capsules prepared by the present invention contain a functional material therein or on the surface, where the expression "containing" means that the functional material is contained or contained within the capsule, and is precipitated or adsorbed on the capsule surface. It may indicate that it is coated. Furthermore, the expression "contains" means that the functional material, together with the polymer, forms the outer layer (shell) of the capsule. It does not exclude forming or supporting in the outer layer.
도 2는 본 발명에 의한 흡착제용 캡슐의 개략도를 나타낸다. 도 3은 본 발명 의 캡슬을 제조하는 장치의 개략도이다. 도 2를 참고하면, 본 발명의 캡술 (100)은 내부영역 (10)과 벽 (20)을 포함한다.  2 shows a schematic view of a capsule for an adsorbent according to the present invention. 3 is a schematic diagram of an apparatus for manufacturing the capsule of the present invention. Referring to FIG. 2, the capsul 100 of the present invention includes an interior region 10 and a wall 20.
상기 내부영역 (10)에는 상기 기능성 물질과 웅고제가 함유된다. 상기 벽 (20) 은 상기 고분자가 응고되면서 흔합용액을 둘러싸 벽체를 형성한다.  The inner region 10 contains the functional material and the ointment. The wall 20 forms a wall surrounding the mixed solution as the polymer solidifies.
상기 벽 (20)의 두께는 1~5,000 , 바람직하게는 10~1,000 일 수 있다.  The thickness of the wall 20 may be 1-5,000, preferably 10-1,000.
도 3을 참고하면, 본 발명의 제조장치는 흔합기 (110), 주입기 (120) 및 캡슐 형성기 (130)를 포함한다.  Referring to FIG. 3, the manufacturing apparatus of the present invention includes a mixer 110, an injector 120, and a capsule former 130.
상기 흔합기 (110)에는 기능성 용액과 웅고제를 흔합하여 흔합용액을 제조한 다. 상기 흔합기에는 추가로 고점도성 물질을 추가로 흔합할 수 있다.  In the mixer 110, a mixed solution is prepared by mixing a functional solution and an ointment agent. The mixer may further mix high viscosity materials.
상기 주입기 (120)는 상기 흔합기 (110)에서 제공되는 흔합용액을 캡슐형성기 (130)로 떨어뜨린다. 상기 주입부 (120)는 흔합용액을 소정 간격으로 적하할 수 있 는 노즐을 구비할 수 있다.  The injector 120 drops the mixed solution provided from the mixer 110 to the capsule former 130. The injection unit 120 may be provided with a nozzle that can drop the mixed solution at predetermined intervals.
본 발명의 제조장치는 상기 흔합용액을 상기 주입부로 제공하는 이송부 (140) 을 포함할 수 있다.  The manufacturing apparatus of the present invention may include a transfer unit 140 for providing the mixed solution to the injection unit.
상기 캡슐 형성기 (130)에는 고분자 용액이 채워져 있다. 상기 캡슐형성기 (130)에서, 상기 흔합용액이 비드 형태로 고분자 용액으로 적하되면, 비드의 계면 과 접촉하는 고분자가 경화되어 소정 두께의 벽을 형성한다.  The capsule former 130 is filled with a polymer solution. In the capsule former 130, when the mixed solution is dropped into the polymer solution in the form of beads, the polymer in contact with the interface of the beads is cured to form a wall of a predetermined thickness.
상기 캡슐 형성기 (130)에는 교반기를 구비할 수 있다.  The capsule former 130 may be provided with a stirrer.
도 4는 상기 캡슐 형성기 (130)에서의 캡슐 형성 과정을 나타낸다. 도 4에서 는 웅고제로 CaC12를 사용한 예이다. 비드 내부에서 이온화된 Ca2+는 비드를 둘러싸 고 있는 고분자 용액으로 확산되고, 이에 의해 용액 중의 고분자가 비드 표면에서 부터 경화된다. 4 illustrates a capsule formation process in the capsule former 130. In FIG. 4, CaC12 is used as an unpacking agent. Ca 2+ ionized inside the beads diffuses into the polymer solution surrounding the beads, thereby curing the polymer in the solution from the bead surface.
본 발명의 방법 및 제조장치는 비드 내부의 웅고제, 예를 들면, Ca2+ 농도 및 캡슐 제조기 (130) 내에서의 고분자 농도를 제어하여 고분자 벽체의 경화 속도나 두께를 임의로 조절할 수 있다. The method and manufacturing apparatus of the present invention can arbitrarily adjust the curing rate or thickness of the polymer wall by controlling the concentration of uncoagulant, such as Ca 2+ , and the polymer concentration in the capsule maker 130 inside the bead.
본 발명의 캡슐 제조방법은 종래 비드나 하이드로겔 제조방법에 비해 다량의 기능성 물질을 함유할 수 있고 종래 기술로는 소수성 기능성 물질을 함유하는 것에 큰 어려움이 많은데 비해 본 발명기술은 소수성 기능성 물질을 손쉽게 함유할 수 있다.  The capsule manufacturing method of the present invention may contain a large amount of functional material compared to the conventional bead or hydrogel manufacturing method, and the conventional technology has a great difficulty in containing a hydrophobic functional material, but the present technology provides a hydrophobic functional material easily. It may contain.
또한, 본 발명기술은 기능성 물질 함유에 따른 고분자 물질 변형과 함유된 기능성 물질의 유출이 없으며 캡슐 두께 조절이 용이하여 물질 전달측면에서도 높 은 흡착속도를 기대할 수 있다. In addition, the present invention is a polymer material modification and containing according to the functional material containing There is no leakage of functional material and the capsule thickness can be easily adjusted, so high adsorption rate can be expected in terms of mass transfer.
<45> 본 발명의 캡슐 제조 방법과 제조장치는 상기 적하단계에 의해 형성된 캡슐 을 별도의 응고제 용액에 주입하는 단계 및 장치를 추가로 포함할 수 있다. 도 5는 도 4에서 제조된 캡슐을 응고제 용액에 주입한 후 나타나는 웅고제의 작용을 보여 준다. 도 4에서는 응고제가 내부에만 존재하지만, 도 5의 경우에는 응고제가 고분 자 외벽에도 있어, 외벽에서부터 내부로 웅고제가 확산되어 고분자 외벽을 좀 더 견고하게 형성시킬 수 있다. The capsule manufacturing method and apparatus of the present invention may further include a step and a device for injecting the capsule formed by the dropping step into a separate coagulant solution. Figure 5 shows the action of the uncoagulant appearing after injecting the capsule prepared in Figure 4 into the coagulant solution. In FIG. 4, the coagulant is present only in the inside, but in the case of FIG. 5, the coagulant is also present in the polymer outer wall, and the uncoagulant diffuses from the outer wall to the inside to form the polymer outer wall more firmly.
<46> 상기 기능성 물질은 금속 환원제, 금속 추출제 및 킬레이팅 화합물중 어느 하나 이상일 수 있다.  The functional material may be any one or more of a metal reducing agent, a metal extractant, and a chelating compound.
<47> 상기 금속환원제는 천연 항산화제인 tocopherol류, flavone유도체, phyl lozurcin류, gal lie acid 유도체, catechin, nordihydroguaiaret ic acid, gossypol, lignan 배당체, 식물추출물 및 금속환원력을 가진 고분자, 글루타르알데 히드 (Glutaraldehyde) , Sodium borohydride(NaBH4) , Hydrazine (Ν2Η4) , The metal reducing agent is a natural antioxidant, tocopherols, flavone derivatives, phyl lozurcins, gal lie acid derivatives, catechin, nordihydroguaiaret ic acid, gossypol, lignan glycosides, plant extracts and polymers having metal reducing power, glutaraldehyde ( Glutaraldehyde), Sodium borohydride (NaBH 4 ), Hydrazine (Ν 2 Η 4 ),
Borohydride, Dimethylamine borane [(CH3)2NH.HBH3] , Formaldehyde [CH20] , Sodium dithionite [Na2S2 ], Ascorbic acid [( ¾06], Ethylene glycol , Sodium alkoxide , Borohydride, Dimethylamine borane [(CH 3 ) 2 NH.HBH 3 ], Formaldehyde [CH 2 0], Sodium dithionite [Na2S2], Ascorbic acid [(¾06], Ethylene glycol, Sodium alkoxide,
Hydroquinone (( ¾02), Sodium oxalate (Na2C2H204) , Formic acid, Dimethylamine borane, Dithiothreitol , 및 Tris (2-carboxyethyl ) phosphine 중에서 선택된 하나 이상일 수 있다. Hydroquinone ((¾0 2), Sodium oxalate (Na 2 C2H 2 0 4), Formic acid, may be at least one selected from Dimethylamine borane, Dithiothreitol, and Tris (2-carboxyethyl) phosphine.
<48> 상기 금속 추출제는 유기인 유도체 (예를 들어, tri isobutyl phosphine sulfide, trioctylphosphine oxide, tri alky lphosphine oxide) , 트리옥틸아민 (trioctylamine), 메칠이소부틸케톤 (methyl isobutyl ketone), 트리옥틸메틸암모늄 염화물 (trioctylmethylammonium chloride) , 디부틸설폭시드 (dibutyl sulfoxide), tris-iso-octyl amine, LIX 841 ( t r i pheny 1 hosph i ne , 2一 hydroxyl— 5一 nonylacetophenoneoxime) , phospho 1 i c acid di (2-ethylhexyl ) ester , tri— butyl phosphate, elex-100(7-(4-ethyl-l-methyloctyl )-8-hydroxyquinol ine) , 알킬 설파 이드 (alkyl sulfides), 포스파인 설파이드 (phosphine sulfide), 하이드록시옥심 (hydroxyoximes) , 2차 아민 (secondary amines) , 3차 아민 (tertiary amines) , 암모 늄 솔트 (a画 onium salt), 트리 -n-뷰틸 포스페이트 (tri-n-butyl phosphate), 퀴놀린 을 유도체, 고분자 아민류 (트리알킬메틸아민, n-도데시닐알킬메틸아민, 트리옥틸아 민), 트리옥틸포스핀옥시드 및 에틸렌디아민아세트산으로 이루어진 군에서 선택된 하나 이상일 수 있다. The metal extractant may be an organophosphorus derivative (eg, tri isobutyl phosphine sulfide, trioctylphosphine oxide, tri alky lphosphine oxide), trioctylamine, methyl isobutyl ketone, trioctylmethyl Trioctylmethylammonium chloride, dibutyl sulfoxide, tris-iso-octyl amine, LIX 841 (tri pheny 1 hosph i ne, 2 一 hydroxyl— 5 一 nonylacetophenoneoxime), phospho 1 ic acid di (2- ethylhexyl) ester, tri—butyl phosphate, elex-100 (7- (4-ethyl-l-methyloctyl) -8-hydroxyquinol ine), alkyl sulfides, phosphine sulfide, hydroxyoxime derivatives (hydroxyoximes), secondary amines, tertiary amines, amonium salts, tri-n-butyl phosphate and quinoline Amines (trialkylmethylamine, n-dodecynylalkylmethylamine, triox Tilamine), trioctylphosphine oxide and ethylenediamineacetic acid There may be more than one.
<49> 상기 킬레이팅제로는 폴리포스페이트 (예를 들어, 트라이플리인산나트륨, 핵 사메타인산, 산성파이로인산나트륨, 파이로인산나트륨, 파이로인산사나트륨, 핵사 메타인산나트륨, 메타인산나트륨); 아미노카르복실산 (예를 들어, 에틸렌다이아민테 트라아세트산 (EDTA), 1, 2-비스 (2-아미노ᅳ페녹시 )에탄 -N ,Ν,Ν'Ν' -테트라아세트산 (EGTA) , 에틸렌비스 (옥시에틸렌니트릴로)테트라아세트산 (ΒΑΡΤΑ), Ν- (하이드록시에 틸 ) -에틸렌다이아민트라이아세트산 (HEDTA) , 다이에틸렌트라이아민펜타아세트산 (DTPA) , Ν-다이하이드록시에틸글리신 (2-HxG), 에틸렌비스 (하이드록시페닐-글리신 )(EHPG), 글루탐산, 아스파르트산, 글리신, 라이신); 1,3—다이케톤 (예를 들어, 아 세틸아세톤, 트라이플루오로아세틸아세톤, 테노일트라이플루오로아세톤, 아스코르 브산); 하이드록시카르복실산 (예를 들어, 타르타르산, 시트르산, 말산, 글루콘산, 페를산, 락트산, 글루쿠론산); 폴리아민 (예를 들어, 다이에틸렌트라이아민, 트라이 에틸렌트라이아민); 아미노알코올 (예를 들어, 트라이에탄올아민, N-하이드록시에틸 에틸렌 -다이아민, 아미노에틸에탄을아민 (AEEA); 페놀 (예를 들어, 다이설포파이로카 테콜, 크로모트로픽산); 아미노페놀 (예를 들어, 옥신설폰산); 쉬프 (Schiff) 염기 ( 예를 들어,다이살리실알데히드 1,2-프로필렌다이이민); 테트라파이를 (예를 들어, 테트라페닐포르핀, 프탈로사이아닌); 실리케이트 (규산칼슘알루미늄, 규산칼슘, 알 루미노규산나트륨, 알루미노규산칼슴나트륨 (수화물), 규산삼칼슴); 황화합물 (예를 들어, 포타슘 에틸 잔네이트, 소듐 다이에틸다이티오카르바메이트, 다이에틸 다이 티오인산, 티오우레아, 황산마그네슘); 합성 마크로사이클릭 화합물 (예를 들어, 핵 사메틸 -[14]-4,11-디이엔 Ν4,2·2.2—크립테이트); 중합체 (예를 들어, 폴리에틸렌이 민, 폴리메타크릴로일아세톤, 폴리 (ρ—비닐벤질이미노다이아세트산)), 포스폰산 (예 를 들어, 니트릴로트라이메틸렌포스폰산, 에틸렌다이아민테트라- (메틸렌포스폰산), 하이드톡시에틸리덴다이포스폰산), 멜라민 L-cystein, Phosphatidylcholone, 알라 민이 포함된다. Examples of the chelating agent include polyphosphate (for example, sodium triplyphosphate, nucleus metaphosphate, sodium pyrophosphate, sodium pyrophosphate, sodium pyrophosphate, sodium metaphosphate and sodium metaphosphate. ); Aminocarboxylic acids (e.g., ethylenediaminetetraacetic acid (EDTA), 1,2-bis (2-amino ᅳ phenoxy) ethane-N, Ν, Ν'Ν'-tetraacetic acid (EGTA), ethylenebis (Oxyethylenenitrilo) tetraacetic acid (ΒΑΡΤΑ), Ν- (hydroxyethyl) -ethylenediaminetriacetic acid (HEDTA), diethylenetriaminepentaacetic acid (DTPA), Ν-dihydroxyethylglycine (2- HxG), ethylenebis (hydroxyphenyl-glycine) (EHPG), glutamic acid, aspartic acid, glycine, lysine); 1,3—diketones (eg, acetylacetone, trifluoroacetylacetone, tenoyltrifluoroacetone , ascorbic acid); Hydroxycarboxylic acids (eg, tartaric acid, citric acid, malic acid, gluconic acid, peric acid, lactic acid, glucuronic acid); Polyamines (eg, diethylenetriamine, triethylenetriamine); Aminoalcohols (eg triethanolamine, N-hydroxyethyl ethylene-diamine, aminoethylethane amine (AEEA); phenols (eg disulfopyrocatechol, chromotropic acid); aminophenol (E.g., oxinsulfonic acid); Schiff base (e.g., disalicylaldehyde 1,2-propylenediimine); tetrapy (e.g., tetraphenylphosphine, phthalocyanine Silicates (aluminum calcium silicates, calcium silicates, sodium aluminosilicates, sodium aluminosilicates (hydrates), tricalcium silicates); sulfur compounds (e.g., potassium ethyl xantate, sodium diethyldithiocarbamate , Diethyl dithiophosphoric acid, thiourea, magnesium sulfate), synthetic macrocyclic compounds (e.g., nucleosamethyl- [14] -4,11-diene N4,2.2.2—cryptate); For example, polyethylene Min, polymethacryloylacetone, poly (ρ-vinylbenzyliminodiacetic acid), phosphonic acid (e.g. nitrilotrimethylenephosphonic acid, ethylenediaminetetra- (methylenephosphonic acid), hydroxy to Thylidenediphosphonic acid), melamine L-cystein, Phosphatidylcholone, and alamin.
<50> 바람직하게는 상기 킬레이팅제로서, 멜라민, L-cystein,  Preferably, as the chelating agent, melamine, L-cystein,
Phosphatidylcholone, 알라민 중 어느 하나를 사용할 수 있다.  Phosphatidylcholone or alamin can be used.
<5i> 상기 웅고제가 폴리인산나트륨 (sodkrni polyphosphate), 염화칼슘, 에탄을, 물 또는 가성소다수용액일 수 있다.  The uncoagulant may be sodium polyphosphate, calcium chloride, ethane, water or caustic soda solution.
<52> 상기 고분자는 키토산, 알지네이트 (alginate), 덱스트란 (dextran), 산화 덱 스트란 (oxidized dextran), 해파란 (heparan), 헤파린 (heparin), 히알루론산 (hyaluronic acid) , 아가로스 (agarose), 카라기난 (carageenan), 아밀로펙틴 (amylopectin), 아밀로즈 (amylose) , 글리코겐 (glycogen), 전분, 샐를로오스, 키틴 , 헤파란 설페이트 (heparan sulfate), 콘드로이틴 설페이트 (chondroitin sulfate), 덱스트란 설페이트 (dextran sulfate), 데르마탄설페이트 (dermatan sulfate), 케라 탄 설페이트 (keratan sulfate), 펙린 (pectins), 잔탄검 (xanthanGum), 카르복시메틸 셀를로오즈, 아크릴아미드의 단독 및 공중합체, 폴리아크릴산, 폴리에틸렌옥시드, 폴리비닐알코올, 폴리비닐알코올-폴리비닐아세테이트 공중합체, 폴리 (N-비닐피를리 돈), 폴리하이드록시에틸아크릴레이트, 폴리설폰, 및 폴리우레탄으로 이루어진 군 에서 선택된 하나 이상일 수 있다. The polymer is chitosan, alginate, dextran, oxidized dextran, heparan, heparin, hyaluronic acid, agarose. ), Carageenan, amylopectin amylopectin, amylose, glycogen, starch, salose, chitin, heparan sulfate, chondroitin sulfate, dextran sulfate, dermatan sulfate dermatan sulfate, keratan sulfate, pectins, xanthanGum, carboxymethyl cellulose, homopolymers and copolymers of acrylamide, polyacrylic acid, polyethylene oxide, polyvinyl alcohol, polyvinyl It may be at least one selected from the group consisting of alcohol-polyvinylacetate copolymer, poly (N-vinylpyridone), polyhydroxyethyl acrylate, polysulfone, and polyurethane.
<53> 상기 고분자는 적절한 용매에 용해하여 사용할 수 있으며, 상기 용매로는 물 The polymer may be dissolved in an appropriate solvent and used as the solvent.
, 알코올, 에테르, 케톤, 이온성 액체, Ν,Ν—디메틸아크릴아마이드 메틸 아실레이트 (Ν,Ν-Dimethylacryl amide Methyl acylate) , 메틸아크릴레이트 (Methyl acrylate) , 메타크릴로나이트릴 (Methacrylonitrile), 메틸 메타크릴레이트 (Methyl - methacrylate), 스티렌 (Styrene), 바이닐 아세테이트 (Vinyl acetate), 바이닐 클로 라이드 (Vinyl chloride), 4-바이닐피리딘 (4-Vinylpyndine), n-바이닐피를리돈( n- Vinylpyrrolidone), 디메틸포름아마이드 (Dimethyl formamide) , 디메틸술폭사이드 (Dimethylsulfoxide), 디페닐아민 (Diphenylamine:), 에틸렌 카보네이트 (Ethylene carbonate) , 염화철 (III)(Iron(ni) chloride), 과염소산 마그네슘 (Magnesium perchiorate), 이산화황 (Sulfur dioxide), 트리에틸아민 (Triethylamine), 트리메틸 아민 (Trimethyl amine), 트리프로필아민 (Tr ipropylamine), 염화아연 (Zinc chloride), 아크릴아마이드 (Acrylamide) 및 아크릴로나이트릴 (Acrylonitri le)으로 이루어진 군에서 선택된 하나 이상을 사용할 수 있다. , Alcohol , ether , ketone , ionic liquid , Ν, Ν-dimethylacrylamide methyl acylate, methyl acrylate, methacrylonitrile, methyl Methyl-methacrylate, Styrene, Vinyl acetate, Vinyl chloride, 4-vinyllpyndine, n-vinylpyrrolidone , Dimethyl formamide, dimethylsulfoxide, diphenylamine: ethylene carbonate, iron (III) iron, magnesium perchlorate, Sulfur dioxide, Triethylamine, Trimethyl amine, Tripropylamine, Zinc chloride, Acrylamide You may use one or more selected from the group consisting of nitriles (Acrylonitri le) acryloyl.
<54> 상기 고분자는 적하된 비드 형태의 흔합용액 외부에서부터 내부로 경화되어 소정 두께의 막을 형성한다.  The polymer is cured from the outside of the bead-shaped mixed solution to the inside to form a film having a predetermined thickness.
<55> 상기 고분자 용액의 농도는 0.01~80%(w/v)이며, 이 고분자용액에 대비하여 기능성 물질은 0.01~50%(w/v) 및 응고제는 0.01~40¾>(w/v)를 사용할 수 있다. The concentration of the polymer solution is 0.01 to 80% (w / v), 0.01 to 50% (w / v) of the functional material and 0.01 ~ 40¾> (w / v) of the coagulant in comparison to the polymer solution Can be used.
<56> 상기 방법은 상기 흔합용액에 고점도성 물질을 추가로 포함하고, 상기 기능 성 물질은 상기 고점도성 물질에 의해 입상화될 수 있다. The method further includes a high viscosity material in the mixed solution, and the functional material may be granulated by the high viscosity material.
<57> 좀 더 구체적으로 설명하면, 상기 고점도성 물질, 상기 기능성 물질 및 상기 웅고제를 물리적으로 흔합된 에멀견 상태로 만든 다음, 이 에멀견 상태의 흔합물의 비드를 상기 고분자 용액에 첨가하게 되면 상기 웅고제에 의해 고분자 용액이 경화 되면서 흔합물 비드를 외부에서 코팅하는 형태로 캡슐을 형성할 수 있다.  In more detail, when the highly viscous material, the functional material and the arch agent are made into a physically mixed emulsion state, beads of the emulsion in the emulsion state are added to the polymer solution. As the polymer solution is cured by the ointment agent, a capsule may be formed in the form of coating the complex beads from the outside.
<58> 본 발명에 따르면 기능성 물질과 고점도성 물질을 흔합하여 소정의 점도를 가진 에멀견 상태로 만들기 때문에 상기 기능성 물질을 캡술 내부에 안정적으로 포 함시킬 수 있다. According to the present invention, a predetermined viscosity is obtained by mixing a functional material and a high viscosity material. The functional substance can be stably contained in the capsule because it is in the state of the excitation emulsion.
상기 기능성 물질이 상기 캡슐 외부로 용출되지 않도록 상기 고점도성 물질 은 상기 기능성 물질 100중량부에 대하여 0.01~50중량부, 바람직하게는 1~20중량부 를 첨가할 수 있다. 0.01 중량부 미만시에는 상기 기능성 물질을 입상화시키는 것 과 상기 캡슐 외부로 용출되는 것을 차단하기 어렵고, 50중량부 초과시에는 과도한 점도로 용액을 적하하기가 어렵다.  The highly viscous material may be added in an amount of 0.01 to 50 parts by weight, preferably 1 to 20 parts by weight, based on 100 parts by weight of the functional material so that the functional material does not elute to the outside of the capsule. If it is less than 0.01 part by weight, it is difficult to block the granulation of the functional material and to elute out of the capsule, and when it exceeds 50 parts by weight, it is difficult to drop the solution with excessive viscosity.
상기 고점도성 물질은 2~10,000 mPa s의 점도를 가진 것을 사용할 수 있다.  The high viscosity material may be used having a viscosity of 2 ~ 10,000 mPa s.
*상기 고점도성 물질은 카르복시메틸 셀를로오즈 (Carboxymethyl Cellulose), 하이드록시에틸 셀롤로오즈 (Hydroxyethyl Cellulose), 잔탄검 (Xanthan Gum), 하이 셀 (Hycel), 카보머 (Carbomer), 젤라틴 (gelat in), 펙틴 (Pectin), 구아검 (Guargum), 알긴산나트륨 (Sodium Alginate), 글리세로인산칼슘 (Calcium Glycerophosphate), 캐 라지난 (Carrageenan), 트래거캔스고무 (tragacanth gum), 알긴산프로필렌글리콜 (Propylene Glycol Alginate), 메틸에틸셀를로스 (Methylethylcel lulose), 알긴산칼 륨 (Potassium Alginate) 및 카복시메틸셀를로스 칼슘 (Calcium Carboxymethylcel lulose)으로 이루어진 군에서 선택된 하나 일 수 있다ᅳ * The highly viscous materials include Carboxymethyl Cellulose, Hydroxyethyl Cellulose, Xanthan Gum, Hycel, Carbomer, Gelatin ), Pectin, Guargum, Sodium Alginate, Calcium Glycerophosphate, Carrageenan, Tragacanth gum, Propylene Glycol Glycol Alginate, Methylethylcel lulose, Potassium Alginate and Carboxymethylcelulose calcium (Calcium Carboxymethylcel lulose)
다른 양상에서 본 발명은 상기 방법에서 제조된 흡착제용 캡슐에 관계한다. 본 발명의 흡착제용 캡슐은 기능성 물질로서 멜라민, L-cystein, Phosphatidylcholone, 디부틸설폭시디 (dibutyl sulfoxide), LIX In another aspect the invention relates to a capsule for adsorbent prepared in the above process. Capsule for the adsorbent of the present invention is a functional material melamine, L-cystein, Phosphatidylcholone, dibutyl sulfoxide, LIX
841 ( t r i heny 1 phosph i ne , 2-hydr oxy 1 -5-nony 1 acet ophenoneox i me ) , 트리옥틸포스핀 옥사이드 (trioctylphosphine oxide), 트리알킬포스핀옥사이드 (trialkylphosphine oxide)를 포함하여 팔라듐에 선택적 흡착능력을 가질 수 있다. 상기 캡슬은 기능 성 물질로서 알라민 (alamine), 메칠이소부틸케톤 (methyl isobutyl ketone)을 포함 하여 금에 대한 선택적 흡착능력을 가질 수 있다. Selective for palladium including 841 (tri heny 1 phosphine, 2-hydroxy 1 -5-nony 1 acet ophenoneox i me), trioctylphosphine oxide, trialkylphosphine oxide It can have adsorption capacity. The capsule may have a selective adsorption capacity for gold, including aamine (alamine), methyl isobutyl ketone as a functional material.
상기 흡착제용 캡슐은 앞에서 언급한 기능성 물질들 중에서 오일 성분을 갖 는 것을 사용하면, 상기 캡슐의 교체 주기를 가시적으로 판단할 수 있다. 오일성 분을 갖는 것은 알라민, 멜라민 등 일 수 있다.  The capsule for the adsorbent may be visually determined by the replacement cycle of the capsule using an oil component among the aforementioned functional materials. Having an oily component may be alumina, melamine and the like.
상기 ¾슐은 유가 금속을 흡착함에 따라 비중이 증가하여 용액 상부에서 바 닥으로 침강하게 된다. 또한, 바닥에 침강된 캡슐을 수거하여 탈착 용액에 넣으면 흡착 금속의 탈착 진행에 따라 용액 상부로 부상하게 된다.  The capsule is settled to the bottom at the top of the solution by increasing the specific gravity as the valuable metal adsorbs. In addition, when the capsule settled on the bottom is collected and put into the desorption solution, the adsorbed metal floats to the top of the desorption process.
<67> <68> 본 발명에 의한 유가금속 회수방법은 특정 유가금속을 선택적으로 회수할 수 있다. 또한, 본 발명에 의한 방법은 유가금속회수에 있어서 고액분리가 가능하므 로 친환경적인 공정을 운용할 수 있다. <67> In the valuable metal recovery method according to the present invention, a specific valuable metal can be selectively recovered. In addition, the method according to the present invention can be separated by solid-liquid separation in valuable metal recovery, it is possible to operate an environmentally friendly process.
<69> 이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하지만, 본 발명이 이들 예로만 한정되는 것은 아니다.  Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited only to these examples.
<70>  <70>
<71> 실시예 1  Example 1
<72> 50mL 1.5% CaC12 solution과 1.5%의 카르복시메틸 샐를로오즈 (CMC) 용액을 섞어준 후 4g의 멜라민을 넣고 잘 섞어 흔합용액을 제조하였다. 상기 흔합용액을 0.6% w/v Na-alginate 용액에 떨어뜨려 5분간 교반하여 캡슐을 수득하였다.  50mL 1.5% CaC12 solution and 1.5% carboxymethyl salloose (CMC) solution were mixed, and 4 g of melamine was added to the mixture to prepare a mixed solution. The mixed solution was dropped in 0.6% w / v Na-alginate solution and stirred for 5 minutes to obtain a capsule.
<73> 상기 수득된 캡술을 세척한 후 2% CaC12 용액 lOOmL에 넣어 30분 정도 교반 하였다. 반웅이 완료된 후 탈이온수로 상기 ¾슐을 수차례 세척하였다.  After washing the capsule obtained above was added to 100 mL of 2% CaC12 solution and stirred for about 30 minutes. After reaction was completed, the ¾ capsule was washed several times with deionized water.
<74>  <74>
<75> 실시예 2  Example 2
<76> 멜라민 대신에 L-Cistein 4g을 넣어주는 것을 제외하고 실시예 1과 동일하게 캡슬을 제조하였다.  A capsule was prepared in the same manner as in Example 1 except for adding 4 g of L-Cistein instead of melamine.
<77>  <77>
<78> 실시예 3  <78> Example 3
<79> 멜라민 대신에 Phosphatidylcholone 4g을 넣어주는 것을 제외하고 실시예 1 과 동일하게 캡슐을 제조하였다.  Capsules were prepared in the same manner as in Example 1 except for adding 4 g of Phosphatidylcholone instead of melamine.
<80>  <80>
<81> 실시예 4  Example 4
<82> 50mL 용액 (1.5% CaC12 solution과 1.5%의 카르복시메틸 셀를로오즈 (CMC) 함 유)에 10ml 알라민올 넣어 혼합용액을 제조하였다. 상기 흔합용액을 0.6% w/v Na- alginate 용액에 떨어뜨려 5분간 교반하여 캡술을 수득하였다.  Into a 50mL solution (1.5% CaC12 solution and 1.5% carboxymethyl cell containing rose (CMC)) 10ml alaminol to prepare a mixed solution. The mixed solution was dropped into 0.6% w / v Naginal solution and stirred for 5 minutes to obtain a capsul.
<83> 상기 수득된 캡슐을 세척한 후 2% CaC12 용액 lOOmL에 넣어 30분 정도 교반 하였다. 반웅이 완료된 후 탈이은수로 상기 캡슐을 수차례 세척하였다.  After the capsules obtained above were washed, 100 ml of 2% CaC12 solution was added and stirred for about 30 minutes. After the reaction was completed, the capsules were washed several times with deionized water.
<84>  <84>
<85> 비교예 1  <85> Comparative Example 1
<86> 0.6% w/v Na-alginate 용액을 2% CaC12 용액 1000ml에 주입하여 상온에서 약  Inject a 0.6% w / v Na-alginate solution into 1000 ml of a 2% CaC12 solution at room temperature
30분간 반웅시켜 비드를 수득하고 이를 수차례 세척하였다.  After 30 minutes of reaction, the beads were obtained and washed several times.
<87> » 시험 <87> " exam
제조된 소재들의 흡착선택성을 평가하기 위하여 Au(III), Pd(II), Pt(IV)의 흔합용액 (0.1M HC1용액에 각 금속이온은 100mg/L씩 함유됨). 상기 실시예 1~3에서 수득한 캡슐 0.05g을 흔합용액에 넣어준 후 1M NaOH와 1M HC1을 사용하여 pH를 2~12의 범위로 조정하면서 흡착을 수행하였다. 도 6은 실시예 1, 실시예 4 비교예 1에서 수득한 캡슐 또는 비드의 전자현미 경 사진이다.  Mixed solution of Au (III), Pd (II), Pt (IV) to evaluate the adsorption selectivity of the prepared materials (each metal ion in 0.1M HC1 solution contains 100mg / L). 0.05 g of the capsules obtained in Examples 1 to 3 were added to a mixed solution, and then adsorption was performed by adjusting the pH to a range of 2 to 12 using 1M NaOH and 1M HC1. Figure 6 is an electron micrograph of the capsule or bead obtained in Example 1, Example 4 Comparative Example 1.
도 6을 참고하면 본 발명의 캡슐은 외벽이 소정 두께로 형성되어 있으나 비 교예 1의 비드에는 본 발명과 같은 소정 두께의 벽이 형성되지 않음을 확인할 수 있다.  Referring to Figure 6, the capsule of the present invention can be seen that the outer wall is formed to a predetermined thickness, but the wall of the predetermined thickness is not formed in the beads of Comparative Example 1.
또한, 도 6에서는 기능성 물질이 고점도성 물질과 흔합되어 에멀견 상태로 입상화되어 있음을 보여준다.  In addition, FIG. 6 shows that the functional material is mixed with the high viscosity material and granulated in an emulsion state.
도 7은 실시예 1의 캡슐을 사용하여 상기 흡착시험을 수행한 것을 보여주는 그래프이고, 도 8은 실시예 2의 캡슐을 사용하여 상기 흡착시험을 수행한 것을 보 여주는 그래프이고, 도 9는 실시예 3의 캡슐을 사용하여 상기 흡착시험을 수행한 것을 보여주는 그래프이다.  7 is a graph showing that the adsorption test was carried out using the capsule of Example 1, Figure 8 is a graph showing that the adsorption test was performed using the capsule of Example 2, Figure 9 is carried out It is a graph showing that the adsorption test was performed using the capsule of Example 3.
도 7를 참고하면, 실시예 1의 캡슐을 사용한 경우, Au은 pH 2 ~ 4에서 흡착 성능이 증가하였고 pH 4 ~ 10에서는 흡착성능이 완만하게 감소하였으며 pH 10부터 는 흡착성능이 급격하게 감소하였다. 반면 Pt의 경우는 pH 10이상에서 흡착성능의 증가를 보였으며 Pd의 경우 pH 전 범위에서 가장 높은 흡착선택성을 보였다. 멜라 민을 함유한 캡슐은 pH 4 내지 pH 12 범위에서 백금에 비해 팔라듐을 선택적으로 흡착하고, 또한, 멜라민을 함유한 캡슐은 pH 2 또는 pH 12 부근에서는 백금과 금 등에 비해 팔라듐에 대한 선택성이 매우 높음을 알 수 있다.  Referring to FIG. 7, in the case of using the capsule of Example 1, Au increased the adsorption performance at pH 2 ~ 4, the adsorption performance was slowly decreased at pH 4 ~ 10 and the adsorption performance rapidly decreased from pH 10 . On the other hand, Pt showed an increase in adsorption performance above pH 10 and Pd showed the highest adsorption selectivity over the entire pH range. Melamine-containing capsules selectively adsorb palladium over platinum in the range of pH 4 to pH 12, and melamine-containing capsules have very high selectivity to palladium over platinum and gold near pH 2 or pH 12. It can be seen that high.
도 8을 참고하면, 실시예 2의 캡술을 사용한 경우, 백금보다는 팔라듐과 금 을 선택적으로 흡착함을 알 수 있다. 즉, pH가 3~6 또는 pH 9 이상인 경우 백금에 비해 팔라듬과 금에 대한 선택성이 우수하다.  Referring to Figure 8, when using the capsul of Example 2, it can be seen that the selective adsorption of palladium and gold rather than platinum. In other words, when the pH is 3 to 6 or more than pH 9, the selectivity to paladin and gold is superior to platinum.
도 9를 참고하면, 실시예 3의 캡슐을 사용한 경우, pH 전영역에 걸쳐 백금과 팔라듐에 비해 금에 대한 선택성이 우수함을 알 수 있다. 지금까지 본 발명의 구체적인 실시예들을 살펴보았다. 본 발명이 속하는 기 술 분야에서 통상의 지식을 가진 자는 본 발명이 본질적인 특성에 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 본 발명의 범위 는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다. Referring to Figure 9, when using the capsule of Example 3, it can be seen that the selectivity to gold is superior to platinum and palladium over the entire pH range. So far, specific embodiments of the present invention have been described. Those of ordinary skill in the art to which the present invention pertains do not depart from the essential characteristics of the present invention. It will be appreciated that the present invention may be embodied in a modified form. The scope of the present invention is shown in the appended claims rather than the foregoing description, and all differences within the scope will be construed as being included in the present invention.
【산업상 이용가능성】  Industrial Applicability
<100> 본 발명은 기능성 물질을 표면이나 내부에 함유하여 유가금속 회수 성능 및 특정 금속에 대한 선택성이 향상된 캡슐 제조방법 및 이에 의한 흡착제용 캡슐에 관한 것으로 유가금속 회수 산업에 이용가능하다.  The present invention relates to a method for preparing a capsule having a functional material contained on or inside a surface thereof, and to improving the valuable metal recovery performance and selectivity with respect to a specific metal, and to a capsule for the adsorbent, which can be used in the valuable metal recovery industry.
<101>  <101>

Claims

【청구의 범위】 [Range of request]
【청구항 1】  [Claim 1]
기능성 물질과 응고제를 흔합하는 단계 ;  Mixing a functional substance with a coagulant;
상기 흔합용액을 고분자 용액에 적하하는 단계로서, 상기 적하단계는 상기 고분자가 상기 비드형태의 흔합용액을 둘러싸 소정 두께의 벽을 형성하는 것을 특 징으로 하는 캡슐 제조방법 .  And dropping the mixed solution into a polymer solution, wherein the dropping step surrounds the bead-shaped mixed solution to form a wall having a predetermined thickness.
【청구항 2】  [Claim 2]
제 1항에 있어서, 상기 방법은 상기 적하 단계에서 형성된 캡슐을 웅고제 용액에 투입하는 단계를 추가로 포함하는 것을 특징으로 하는 ¾슬 제조방법. The method of claim 1, wherein the method further comprises the step of injecting the capsule formed in the dropping step into the uncoagulant solution.
【청구항 3]  [Claim 3]
제 1항에 있어서, 상기 기능성 물질은 금속 환원제, 금속 추출제 및 킬레이팅 화합 물중 어느 하나 이상인 것을 특징으로 하는 캡슐 제조방법. The method of claim 1, wherein the functional material is at least one of a metal reducing agent, a metal extractant, and a chelating compound.
【청구항 4】  [Claim 4]
제 3항에 있어서, 상기 금속환원제는 천연 항산화제인 tocopherol류, flavone유도 체, phyllozurcin류, gal lie acid 유도체 , catechin, nordihydroguaiaret ic acid, gossypol, lignan 배당체, 식물추출물 및 금속환원력을 가진 고분자, 글루타르알데 히드 (Glutaraldehyde), Sodium borohydr ide(NaBH ) , Hydrazine (Ν2Η4) , 4. The metal reducing agent according to claim 3, wherein the metal reducing agent is a natural antioxidant, tocopherols, flavone derivatives, phyllozurcins, gal lie acid derivatives, catechin, nordihydroguaiaretic acid, gossypol, lignan glycosides, plant extracts, and metal-reducing agents, glutarum Aldehyde (Glutaraldehyde), Sodium borohydride (NaBH), Hydrazine (Ν 2 Η 4 ),
Borohydride, Dimethyl amine borane [(C¾)2NH.HB ], Formaldehyde [CH20] , Sodium dithionite [Na2S204] , Ascorbic acid [C6H806] , Ethylene glycol , Sodium alkoxide, Borohydride, Dimethyl amine borane [(C¾) 2NH.HB], Formaldehyde [CH 2 0], Sodium dithionite [Na 2 S 2 0 4 ], Ascorbic acid [C 6 H 8 0 6 ], Ethylene glycol, Sodium alkoxide,
Hydroquinone (( ¾02), Sodium oxalate (N C2H204), Formic acid, Dimethyl amine borane, Dithiothreitol , 및 Tris (2-carboxyethyl) phosphine 중에서 선택된 하나 이상인 것을 특징으로 하는 캡슐 제조방법. A method for preparing a capsule, characterized in that at least one selected from hydroquinone ((¾0 2 ), sodium oxalate (N C2H 2 04), formic acid, dimethyl amine borane, dithiothreitol, and tris (2-carboxyethyl) phosphine.
【청구항 5】  [Claim 5]
제 3항에 있어서, 상기 킬레이팅제는 멜라민, L-cystein, Phosphatidylcholone, 알 라민, 폴리포스페이트, 아미노카르복실산. 1,3-다이케톤, 하이드록시카르복실산, 폴리아민 및 아미노알코을 중 어느 하나 이상인 것을 특징으로 하는 캡슐 제조방 4. The chelating agent of claim 3 wherein the chelating agent is melamine, L-cystein, Phosphatidylcholone, alamin, polyphosphate, aminocarboxylic acid. 1,3-diketone, hydroxycarboxylic acid, polyamine and amino alcohol of any one or more of the capsule manufacturing room
【청구항 6] [Claim 6]
제 3항에 있어서, 상기 금속 추출제는 유기인 유도체 (예를 들어, tr i isobutyl hosphine sulfide, tr ioctylphosphine oxide, tr ialkylphosphine oxide), 트리옥틸아민 (trioctylamine), 메칠이소부틸케톤 (methyl isobutyl ketone) , 트리옥틸메틸암모늄 염화물 (trioctylmethyla瞧 onium chloride), 디부틸설 폭시드 (dibutyl sulfoxide) , tris-iso-octyl amine, LIX 841 ( t r i heny 1 phosph i ne , 2-hydr oxy 1 -5-nony 1 ace t ophenoneox i me ) , phosphol ic acid di (2-ethylhexyl ) ester , tri-butyl phosphate, Kelex-100(7-(4-ethyl-l-methyloctyl )一8— hydroxy qui no 1 ine), 알킬 설파이드 (alkyl sulfides), 포스파인 설파이드 (phosphine sulfide), 하이드록 시옥심 (hydroxyoximes), 2차 아민 (secondary amines) , 3차 아민 (tertiary amines) , 암모늄 솔트 (ammonium salt) , 트리ᅳ n-뷰틸 포스페이트 (tri-n-butyl phosphate), 퀴놀린을 유도체, 고분자 아민류 (트리알킬메틸아민, n—도데시닐알킬메 틸아민, 트리옥틸아민), 트리옥틸포스핀옥시드 및 에틸렌디아민아세트산으로 이루 어진 군에서 선택된 하나 이상인 것을 특징으로 하는 캡슐 제조방법. The method of claim 3, wherein the metal extracting agent is an organophosphorus derivative (e.g., tr i isobutyl hosphine sulfide, tr ioctylphosphine oxide, tr ialkylphosphine oxide), trioctylamine, methyl isobutyl ketone), trioctylmethylamonium chloride, dibutyl sulfoxide, tris-iso-octyl amine, LIX 841 (tri heny 1 phosphine, 2-hydr oxy 1 -5- nony 1 ace t ophenoneox i me), phosphol ic acid di (2-ethylhexyl) ester, tri-butyl phosphate, Kelex-100 (7- (4-ethyl-l-methyloctyl) 一 8— hydroxy qui no 1 ine) , Alkyl sulfides, phosphine sulfides, hydroxyoximes, secondary amines, tertiary amines, ammonium salts, tribune n- Tri-n-butyl phosphate, quinoline derivatives, polymeric amines (trialkylmethylamine, n—dodecynylalkylmethylamine, trioctylamine), trioctylphosphineoxide and ethylenediamineacetic acid Capsule production method characterized in that at least one selected from the group.
【청구항 71  [Claim 71
제 1항에 있어서, 상기 고분자는 키토산, 알지네이트 (alginate), 덱스트란 (dextran) , 산화 덱스트란 (oxidized dextran), 헤파란 (heparan), 헤파린 (heparin), 히알루론산 (hyaluronic acid), 아가로스 (agarose) , 카라기난 (carageenan), 아밀로 펙틴 (amylopectin), 아밀로즈 (amylose), 글리코겐 (glycogen) , 전분, 셀롤로오스, 키틴, 헤파란 설페이트 (heparan sulfate), 콘드로이틴 설페이트 (chondroitin sulfate), 덱스트란 설페이트 (dextran sulfate), 데르마탄설페이트 (dermatan sulfate), 케라탄 설페이트 (keratan sulfate), 펙틴 (pectins), 잔탄검 (xanthanGum) , 카르복시메틸셀를로오즈, 아크릴아미드의 단독 및 공중합체, 폴리아 크릴산, 폴리에틸렌옥시드, 폴리비닐알코올, 폴리비닐알코올—폴리비닐아세테이트 공중합체, 폴리 (Ν—비닐피롤리돈), 폴리하이드톡시에틸아크릴레이트, 폴리설폰, 및 폴리우레탄으로 이루어진 군에서 선택된 하나 이상인 것을 특징으로 하는 캠슐 제 조방법 . According to claim 1, wherein the polymer is chitosan, alginate, dextran, oxidized dextran, heparan, heparin, hyaluronic acid, agarose (agarose), carageenan, amylopectin, amylopectin, amylose, glycogen, starch, cellulose, chitin, heparan sulfate, chondroitin sulfate, Dextran sulfate, dermatan sulfate, keratan sulfate, pectin, pectins, xanthanGum, carboxymethylcellose, homopolymers and copolymers of acrylamide, polya Krylic acid, polyethylene oxide, polyvinyl alcohol, polyvinyl alcohol—polyvinylacetate copolymer, poly (Ν—vinylpyrrolidone), polyhydroxyethyl acrylate, polysulfate Kaemsyul Article method, and poly group consisting of polyurethane, characterized in that at least one selected.
【청구항 8】  [Claim 8]
제 1항에 있어서, 상기 방법은 상기 흔합용액에 고점도성 물질을 추가로 포함하고, 상기 기능성 물질은 상기 고점도성 물질에 의해 입상화된 것을 특징으로 하는 캡슐 제조방법. The method of claim 1, wherein the method further comprises a high viscosity material in the mixed solution, and the functional material is granulated by the high viscosity material.
【청구항 9]  [Claim 9]
제 7항에 있어서, 상기 고점도성 물질은 카르복시메틸 샐롤로오즈 (Carboxymethyl Cellulose), 하이드록시에틸 셀를로오즈 (Hydroxyethyl Cellulose), 잔탄검 (Xanthan Gum), 하이셀 (Hycel), 카보머 (Carbomer ), 젤라틴 (gelatin), 펙틴 (Pectin), 구아검 (Guargum), 알긴산나트륨 (Sodium Alginate), 글리세로인산칼슘 (Calcium Glycerophosphate), 캐라지난 (Carrageenan), 트래거캔스고무 (tragacanth gum) , 알 긴산프로필렌글리콜 (Propylene Glycol Alginate), 메틸에틸샐를로스The method of claim 7, wherein the high viscosity material is Carboxymethyl Cellulose, Hydroxyethyl Cellulose, Xanthan Gum, Hycel, Carbomer , Gelatin, Pectin, Guargum, Sodium Alginate, Glycerophosphate (Calcium Glycerophosphate, Carrageenan, tragacanth gum, Propylene Glycol Alginate, Methylethylsalose
(Methylethylcel lulose), 알긴산칼륨 (Potassium Alginate) 및 카복시메틸셀롤로스 칼슴 (Calcium Carboxymethylcel lulose)으로 이루어진 군에서 선택된 하나 인 것을 특징으로 하는 캡슐 제조방법 . (Methylethylcel lulose), Potassium alginate (Potassium Alginate) and carboxymethyl cellulose calum (Calcium Carboxymethylcel lulose) A method for producing a capsule, characterized in that one selected from the group consisting of.
【청구항 10】  [Claim 10]
제 1항에 있어서, 상기 웅고제가 폴리인산나트륨 (sodium polyphosphate), 염화칼 슘, 에탄올, 물 또는 가성소다수용액인 것을 특징으로 하는 캡슐 제조방법. The method according to claim 1, wherein the uncoagulant is sodium polyphosphate, calcium chloride, ethanol, water or caustic soda solution.
【청구항 11】  [Claim 11]
제 1항 내지 제 10항 증 어느 한 항에 따라 제조된 흡착제용 캡슐. A capsule for adsorbent prepared according to any one of claims 1 to 10.
【청구항 12]  [Claim 12]
제 11항에 있어서, 상기 캡슐은 기능성 물질로서 멜라민, L-cystein, Phosphatidyl chol one, 디부틸설폭시디 (dibutyl sulfoxide), LIXThe method of claim 11, wherein the capsule is a functional substance melamine, L-cystein, Phosphatidyl chol one, dibutyl sulfoxide, LIX
841 ( t r i pheny 1 hosph i ne , 2-hydr oxy 1 -5-nony 1 ace t ophenoneox i me ) , tr ioctylphosphine oxide, tr ialkylphosphine oxide을 포함하여 팔라듐에 선택적 흡착능력을 가지는 것을 특징으로 흡착제용 캡슐. 841 (t r pheny 1 hosph i ne, 2-hydr oxy 1 -5-nony 1 ace t ophenoneox i me), a capsule for adsorbent, characterized in that it has a selective adsorption capacity to palladium, including tr ioctylphosphine oxide and tr ialkylphosphine oxide.
【청구항 13]  [Claim 13]
제 10항에 있어서, 상기 캡술은 기능성 물질로서 알라민 (alamine), 메칠이소 부틸케톤 (methyl isobutyl ketone)을 포함하여 금에 대한 선택적 흡착능력을 가지 는 것을 특징으로 하는 흡착제용 캡슐.  The capsule of claim 10, wherein the capsul has a selective adsorption capacity to gold, including aamine and methyl isobutyl ketone as functional materials.
PCT/KR2014/001070 2013-02-19 2014-02-07 Method for manufacturing capsule and capsule for absorbent which is obtained therefrom WO2014129763A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020130017272A KR101513792B1 (en) 2013-02-19 2013-02-19 Method for preparing capsule and sorbent using the capusle
KR10-2013-0017272 2013-02-19

Publications (1)

Publication Number Publication Date
WO2014129763A1 true WO2014129763A1 (en) 2014-08-28

Family

ID=51391506

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2014/001070 WO2014129763A1 (en) 2013-02-19 2014-02-07 Method for manufacturing capsule and capsule for absorbent which is obtained therefrom

Country Status (2)

Country Link
KR (1) KR101513792B1 (en)
WO (1) WO2014129763A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102415047B1 (en) * 2015-03-18 2022-06-30 전북대학교산학협력단 Chitosan Core-shell adsorbent and method for preparing the same
KR102580230B1 (en) * 2018-04-27 2023-09-19 전북대학교산학협력단 Cationic barrier adsorbent and method for preparing the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510008A (en) * 1994-11-30 1998-09-29 アライドシグナル・インコーポレーテッド Use of a solvent-impregnated crosslinked matrix to recover metals
JP2003113427A (en) * 2001-10-09 2003-04-18 Takashi Kobayashi Microcapsule containing metal extractant
JP2007503293A (en) * 2003-08-22 2007-02-22 ダニスコ エイ/エス Micro capsule
JP2011189264A (en) * 2010-03-15 2011-09-29 Mitsubishi Paper Mills Ltd Metal extracting agent-including magnetic capsule and water treatment method
KR20130055168A (en) * 2011-11-18 2013-05-28 전북대학교산학협력단 Polymer gel containing metal extractant, method for manufacturing the same and method for recovering precious metal using the same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510008A (en) * 1994-11-30 1998-09-29 アライドシグナル・インコーポレーテッド Use of a solvent-impregnated crosslinked matrix to recover metals
JP2003113427A (en) * 2001-10-09 2003-04-18 Takashi Kobayashi Microcapsule containing metal extractant
JP2007503293A (en) * 2003-08-22 2007-02-22 ダニスコ エイ/エス Micro capsule
JP2011189264A (en) * 2010-03-15 2011-09-29 Mitsubishi Paper Mills Ltd Metal extracting agent-including magnetic capsule and water treatment method
KR20130055168A (en) * 2011-11-18 2013-05-28 전북대학교산학협력단 Polymer gel containing metal extractant, method for manufacturing the same and method for recovering precious metal using the same

Also Published As

Publication number Publication date
KR101513792B1 (en) 2015-04-21
KR20140104553A (en) 2014-08-29

Similar Documents

Publication Publication Date Title
KR101359988B1 (en) Hydrogel having reducing agents and method for preparing the same
CN106076249B (en) A kind of method of modified alta-mud preparation heavy metal particles adsorbent
CN108261930A (en) A kind of polymer of indium contains liquid film, preparation method and applications
CN103930213A (en) Mineral processing using a polymeric material that includes a moiety which selectively binds to a mineral
CN105061607B (en) A kind of lithium ion imprinted polymer and preparation method thereof
Wei et al. Poly (styrenesulfonic acid)-impregnated alginate capsule for the selective sorption of Pd (II) from a Pt (IV)-Pd (II) binary solution
DE102008012223A1 (en) picolylamine resins
CN102391853A (en) Swelling-resistant shrinking and swelling agent and preparation method thereof
CN104815693A (en) Precious metal nanoparticle-modified porous carrier catalytic material and preparation method thereof
WO2013061109A1 (en) Methods of preparing metal quantum clusters in molecular confinement
WO2014129763A1 (en) Method for manufacturing capsule and capsule for absorbent which is obtained therefrom
EA038541B1 (en) Leaching aids and methods of using leaching aids
Liu et al. Novel Technology for the Removal of Fe and Al from Spent Li-Ion Battery Leaching Solutions by a Precipitation–Complexation Process
KR101531231B1 (en) Microalgae bead, and preparing method of the same
EP3156128B1 (en) Ion exchange resin and method for adsorbing and separating metal
WO2020027009A1 (en) Cellulose derivative, heavy metal removing material containing same, and heavy metal removing method using same
CN107057094B (en) A kind of efficient asphalt agglutination inhibitor and preparation method thereof
CN103028379B (en) Preparation method of coal-based chelate sorbent
CN104826608A (en) Method for degrading orange II in wastewater by using porous chitosan gel beads prepared by using amino protection-modification-release method
CN112961667A (en) Slow-release tracing proppant and preparation method and application thereof
CN106582569A (en) Ion imprinted impregnating resin and preparation method thereof
KR20130123341A (en) Hydrogel having reducing agents and method for preparing the same
CN106831514A (en) The preparation method and heavy metal chelant of heavy metal chelant
CN108249524A (en) A kind of Zero-valent Iron-iron copper micro-electrolysis stuffing and preparation method thereof
CN104774158A (en) Novel preparation method for ornithine aspartate

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14753574

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14753574

Country of ref document: EP

Kind code of ref document: A1